Skip to main content

Monument Reports Third Quarter Fiscal 2026 Results

Gross Revenue of US$47.04 Million and Cash Cost of US$1,390/Oz VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its financial results for the three months (“Q3 FY 2026”) and nine months ended March 31, 2026 (“YTD FY 2026”). All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). President and CEO Cathy Zhai commented, “We are very pleased that the Company has reached a net profit of $22.65 million during Q3, or net earnings of $0.07 per share, which bringing year to date net profit to $53.31 million, or net earnings of $0.15/share. The Selinsing Gold Mine in Malaysia continues delivering favorable production results, together with high gold price, the Company’s...

Continue reading

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three months ended March 31, 2026 (“Q1 2026”), and provided an update on recent corporate developments. Q1 2026 Financial HighlightsResearch and development (R&D) expenses of $1,031,556, up from $885,594 in Q1 2025, reflecting expanded chemistry, AI research, and contract research activity supporting the advancement of the Company’s AI-powered oncology pipeline. General and administrative (G&A) expenses of $443,986, down from $1,224,752 in Q1 2025 — a reduction of approximately 64% — reflecting...

Continue reading

PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results

First quarter 2026 revenue up 79.4% compared to the first quarter of 2025 First quarter 2026 gross profit increased 71.9% compared to the first quarter of 2025 First quarter same-store sales were up 7.3%, and same-store prescription sales were up 7.2%, both compared to the first quarter of 2025SASKATOON, Saskatchewan, June 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the first quarter ended March 31, 2026. “We further scaled our business in the first quarter by successfully integrating our recent pharmacy acquisitions, and advancing our unique and expanding pipeline of additional M&A opportunities,” said Alan Simpson, Executive Chairman of PharmaCorp. “We believe our growth...

Continue reading

Rocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Management to Host Conference Call Tomorrow at 9:00 a.m. ET DURANGO, Colo., June 01, 2026 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory, Inc. (Nasdaq: RMCF) (the “Company”, “RMCF”, or “Rocky Mountain Chocolate Factory”), America’s Chocolatier™, is reporting financial and operating results for its fiscal fourth quarter and full year ended February 28, 2026. “As outlined in our preliminary results announcement last month, fiscal 2026 was a year of significant operational transformation for Rocky Mountain Chocolate Factory,” said Jeff Geygan, Interim CEO. “While fourth quarter sales were impacted by challenges within our packaged product assortment and several temporary factors, we made substantial progress improving the underlying economics of the business. Through pricing, product mix and operational initiatives, we...

Continue reading

Argo Corporation Reports First Quarter 2026 Financial Results

TORONTO, June 01, 2026 (GLOBE NEWSWIRE) — Argo Corporation (TSXV: ARGH) (OTCQX: ARGHF) (“Argo” or the “Company”), a leader in next-generation transit solutions, announced its financial results for the quarter ended March 31, 2026 (“Q1 2026”). All figures are in Canadian dollars unless otherwise noted. The Company’s Q1 2026 financial and business highlights included the following:Revenue: Revenue from continuing operations increased by approximately 474% to $2.9 million in Q1 2026, compared to $0.5 million in Q1 2025. Municipal Agreements: During the quarter, Argo successfully renewed and expanded its transit services agreement with the Town of Bradford West Gwillimbury and continued service delivery under its agreement with the City of Brampton. Net Income: Net income from continuing operations was $1.0 million in Q1 2026, compared...

Continue reading

SHARC Energy Announces Q1 2026 Financial Results

VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) is pleased to announce it has filed financial results for the three months ended March 31, 2026. All figures are in Canadian Dollars and in accordance with IFRS unless otherwise stated. First Quarter Financial Highlights:As of June 1, 2026, the Company has a Sales Pipeline1 of 19M and Sales Order Backlog2 of $6.9M. This represents a $3.5M net increase or 102% increase in Sales Order Backlog since December 1, 2025 disclosure and nominal increases since the April 30, 2026 disclosure. Sales Pipeline saw a 15% increase since December 1, 2025 disclosure reflecting the deliberate efforts by the Company to refill the pipeline once projects convert to the order...

Continue reading

Q.E.P. Co., Inc. Reports Fiscal 2026 Full Year Financial Results

BOCA RATON, Fla., June 01, 2026 (GLOBE NEWSWIRE) — Q.E.P. CO., INC. (OTCQX: QEPC) (the “Company” or “QEP”) today reported financial results for its fiscal year ended February 28, 2026. Net sales for fiscal 2026 were $233.7 million, compared to $243.8 million for fiscal 2025, a decrease of $10.1 million, or 4.1%. The decrease primarily reflected continued softness in home improvement spending, which the Company believes was influenced by elevated interest rates, inflationary pressures and broader macroeconomic uncertainty. The Company continued to invest in its sales organization and customer development initiatives during fiscal 2026. Gross profit for fiscal 2026 was $82.6 million, compared to $86.6 million in the prior year, a decrease of $4.0 million or 4.5%. As a percentage of net sales, gross margin was 35.4% in fiscal 2026,...

Continue reading

NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update

TORONTO, Ontario and HAIFA, Israel, June 01, 2026 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce its financial results for the first quarter ended March 31, 2026, and to provide a corporate update on recent activities and upcoming milestones. The Company’s full set of unaudited condensed interim consolidated financial statements for the three months ended March 31, 2026, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.nurexone.com and its SEDAR+ profile at www.sedarplus.ca. Key Business HighlightsOn January 30, 2026, the Company announced the appointment of Mr. Eyal Gabbai to its Board of Directors, bringing...

Continue reading

FLUENT Reports First Quarter 2026 Results

Q1 2026 Revenue of $17.9MEnded quarter with $8.3 million of cash and cash equivalentsReceived net proceeds of $5.7 million from interim financingContinued progress on Vireo transaction and Texas divestiture TAMPA, Fla., June 01, 2026 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the first quarter ended March 31, 2026. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management CommentaryCost reduction across the base business remained a top priority for the leadership team during Q1 2026, resulting in a year-over-year reduction of more than 20% in total operating expenses. “The Company remained focused on key strategic priorities in the quarter,...

Continue reading

SAIC Announces First Quarter of Fiscal Year 2027 Results

Revenues of $1.91 billion, approximately 2% growth; 0.5% organic growth(1) adjusted for SilverEdge acquisition Net bookings of $2.1 billion; quarterly book-to-bill ratio of 1.1; trailing twelve months book-to-bill ratio of 1.0 Net income of $115 million; Adjusted EBITDA(1) of $222 million or 11.6% of revenues Diluted earnings per share of $2.61; Adjusted diluted earnings per share(1) of $3.23 Cash flows provided by operating activities of $127 million; Free cash flow(1) of $118 million Company increases fiscal year 2027 guidance for adjusted EBITDA(1), adjusted EBITDA margin %(1) and adjusted diluted EPS(1); reiterates revenue and free cash flow(1) guidanceRESTON, Va., June 01, 2026 (GLOBE NEWSWIRE) — Science Applications International Corporation (NASDAQ: SAIC), a premier mission integrator driving our nation’s digital...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.